- Home
- GNLX vs RANG Comparison
GNLX vs RANG Comparison
Compare GNLX & RANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- RANG
- Stock Information
- Founded
- GNLX 2001
- RANG 2024
- Country
- GNLX United States
- RANG United States
- Employees
- GNLX N/A
- RANG N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- RANG
- Sector
- GNLX Health Care
- RANG
- Exchange
- GNLX Nasdaq
- RANG Nasdaq
- Market Cap
- GNLX 184.4M
- RANG 159.6M
- IPO Year
- GNLX 2023
- RANG 2024
- Fundamental
- Price
- GNLX $4.81
- RANG $10.01
- Analyst Decision
- GNLX Strong Buy
- RANG
- Analyst Count
- GNLX 4
- RANG 0
- Target Price
- GNLX $18.25
- RANG N/A
- AVG Volume (30 Days)
- GNLX 331.4K
- RANG 15.6K
- Earning Date
- GNLX 03-31-2025
- RANG 01-01-0001
- Dividend Yield
- GNLX N/A
- RANG N/A
- EPS Growth
- GNLX N/A
- RANG N/A
- EPS
- GNLX N/A
- RANG N/A
- Revenue
- GNLX $8,000.00
- RANG N/A
- Revenue This Year
- GNLX N/A
- RANG N/A
- Revenue Next Year
- GNLX N/A
- RANG N/A
- P/E Ratio
- GNLX N/A
- RANG N/A
- Revenue Growth
- GNLX N/A
- RANG N/A
- 52 Week Low
- GNLX $1.60
- RANG $9.91
- 52 Week High
- GNLX $8.67
- RANG $10.64
- Technical
- Relative Strength Index (RSI)
- GNLX 58.52
- RANG N/A
- Support Level
- GNLX $4.62
- RANG N/A
- Resistance Level
- GNLX $5.76
- RANG N/A
- Average True Range (ATR)
- GNLX 0.57
- RANG 0.00
- MACD
- GNLX -0.03
- RANG 0.00
- Stochastic Oscillator
- GNLX 59.96
- RANG 0.00
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About RANG Range Capital Acquisition Corp. Ordinary Shares
Range Capital Acquisition Corp is a blank check company.